Therefore, inhibition of PDGFRA or EPHA2 only was not sufficient to block PDGFA function but concurrent suppression of the two kinases could be promising regimen for GBM treatment (Fig. 7e). This evidence concerns the gene PDGFRA and glioblastoma.